RT Magazine

RT Magazine Visit us at www.respiratory-therapy.com

RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers.

A 28-year-old cystic fibrosis patient underwent a 36-hour quadruple organ transplant for both lungs, a liver, and a kidn...
05/28/2026

A 28-year-old cystic fibrosis patient underwent a 36-hour quadruple organ transplant for both lungs, a liver, and a kidney
https://buff.ly/Q8iLX2o

A 28-year-old cystic fibrosis patient underwent a 36-hour quadruple organ transplant for both lungs, a liver, and a kidney.

Ventilator recall alert from the FDA https://buff.ly/DIuCOIX
05/27/2026

Ventilator recall alert from the FDA
https://buff.ly/DIuCOIX

React Health is removing certain VOCSN V+Pro units due to a potential oxygen leak condition prior to or during ventilation.

35% of women report menopause-related sleep disruptions https://buff.ly/FynGBcs
05/27/2026

35% of women report menopause-related sleep disruptions
https://buff.ly/FynGBcs

More than 35% of women age 45-64 report frequent nighttime waking and night sweats caused by menopause hormonal changes.

2-time NASCAR champ Kyle Busch died last week from severe pneumonia that escalated into sepsis https://buff.ly/ea9imAC ...
05/27/2026

2-time NASCAR champ Kyle Busch died last week from severe pneumonia that escalated into sepsis
https://buff.ly/ea9imAC

Two-time NASCAR champion driver Kyle Busch (41) died Thursday from severe pneumonia that progressed into sepsis.

Early use of fast identification and antimicrobial susceptibility testing could prevent 36,200 deaths and 84,400 sepsis ...
05/20/2026

Early use of fast identification and antimicrobial susceptibility testing could prevent 36,200 deaths and 84,400 sepsis cases annually
https://buff.ly/dj1uEvr

A new analysis shows that early use of rapid testing for bloodstream infections reduces sepsis progression and healthcare expenses.

Tozorakimab reduced annual exacerbations for moderate-to-severe COPD patients, including former and current smokers http...
05/19/2026

Tozorakimab reduced annual exacerbations for moderate-to-severe COPD patients, including former and current smokers
https://buff.ly/Xh7snXf

Tozorakimab significantly lowered the rate of moderate-to-severe respiratory worsening in COPD patients regardless of smoking history.

Phase 1 trial results for the inhaled nitric oxide therapy ALX1 expected at ATS 2026 https://buff.ly/jCU6vH1 ...
05/19/2026

Phase 1 trial results for the inhaled nitric oxide therapy ALX1 expected at ATS 2026
https://buff.ly/jCU6vH1

Phase 1 results for the inhaled drug candidate ALX1 focus on safety and pharmacokinetics for the treatment of serious lung diseases.

Viz pulmonary suite offers a pulmonary embolism component that reduced time to treatment from 1.75 days to 0.56 days htt...
05/19/2026

Viz pulmonary suite offers a pulmonary embolism component that reduced time to treatment from 1.75 days to 0.56 days
https://buff.ly/BQHVwL7

The new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.

Benralizumab (Fasenra) approved to reduce flare ups of hypereosinophilic syndrome https://buff.ly/NaVGC2h ...
05/18/2026

Benralizumab (Fasenra) approved to reduce flare ups of hypereosinophilic syndrome
https://buff.ly/NaVGC2h

Benralizumab (Fasenra) is now indicated to reduce the risk of flare ups for adult and pediatric patients with hypereosinophilic syndrome.

Tuberculosis drains 0.8% of the world’s economic potential annually, primarily within South Asia and sub-Saharan Africa ...
05/18/2026

Tuberculosis drains 0.8% of the world’s economic potential annually, primarily within South Asia and sub-Saharan Africa
https://buff.ly/T03FGxt

Tuberculosis drains 0.8% of the world's economic potential annually, disproportionately affecting low- and middle-income countries.

Address

7300 W 110th Street, Floor 7
Overland Park, KS
66210

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+19139552600

Website

Alerts

Be the first to know and let us send you an email when RT Magazine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category